Teva Pharma (TEVA) volatility comes in after solid Q4 and outlook
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $34.64 +3.59%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -3.6%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -3.6%
Join SI Premium – FREE
Teva Pharma (NYSE: TEVA) February call option implied volatility is at 38 compared to a level of 56 from last week, March is at 31; compared to its 52-week range of 19 to 50 after solid Q4 and outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX (SPCX) call put ratio 2 calls to 1 put as share price at $160
- Burry says he is short Micron
- Alcoa (AA) call put ratio 1 call to 1 put on 29K contracts as share price down 10%
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
